Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty - Related Studies

Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty

This study has been completed.

Study NCT00001181. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Polyostotic Fibrous Dysplasia
		Precocious Puberty

2	Additional conditions recognized in this trial
		Fibrous Dysplasia of Bone
		Fibrous Dysplasia, Polyostotic
		Puberty, Precocious

3	More general conditions related to this trial
		Bone Diseases
		Bone Diseases, Developmental
		Endocrine System Diseases
		Gonadal Disorders
		Musculoskeletal Diseases
		Osteochondrodysplasias

4	Interventions listed in this trial
		Testolactone

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)